Feasibility For Rare Disease Clinical Trials credevo

Feasibility for rare disease clinical trials is not just a preliminary check. It is a strategic driver that shapes trial outcomes. With small patient populations, strict inclusion criteria, and limited site expertise, feasibility must be grounded in reality from the start. In rare disease research, every early decision carries weight. Misjudging patient availability, site readiness, […]

Read More →
Early Engagement Strategies In Clinical Trials That Drive Site Commitment & Enrollment

Early engagement strategies in clinical trials are one of the most underestimated yet critical factors in overcoming persistent challenges such as enrollment delays, low site motivation, and early site dropouts. Despite increasing complexity in trial designs, many sponsors still treat early engagement and feasibility as routine administrative tasks rather than strategic levers. In reality, early […]

Read More →
FSP Model in Thailand Credevo

The FSP model in Thailand is rapidly transforming how global clinical trials are conducted by combining local expertise with international best practices. In this model, dedicated teams in Thailand handle specific trial functions, helping sponsors achieve faster approvals, smoother site management, and better patient recruitment. We will discuss this model in detail throughout the article, […]

Read More →
Trackers_in_ClinicalTrial_Credevo

Trackers in clinical trials are essential tools that help teams stay organized while enhancing oversight, improving accuracy, and ensuring smooth operational control. From patient enrollment to regulatory timelines, trackers make it easier to manage complex tasks, keep everything on schedule, and support better decision-making throughout the trial. Trackers in clinical trials play a vital role […]

Read More →
Site Engagement in Clinical Trial

Site engagement plays a key role in the success of clinical trials. Starting engagement at the right time and managing it well can make the trial process easier and more efficient. Using engagement strategies from the planning stage to post-trial collaboration helps overcome challenges like patient recruitment, ensures compliance, and improves data quality. This approach […]

Read More →
quality by design in clinical trials

Successful clinical trials are undoubtedly the result of a well-implemented Quality Management System (QMS), and integrating Quality by Design in clinical trials ensures that this system goes beyond merely fulfilling regulatory requirements.  Incorporating a proactive approach like Quality by Design (QbD) while configuring a QMS structure for clinical trials raises the probability of risk management […]

Read More →
Challenges in Oncology Clinical Trials

Oncology clinical trials play a crucial role in addressing the current global cancer crisis, which affects millions of people worldwide. According to the World Health Organization and other research bodies, cancer remains one of the leading causes of death globally. Efforts to combat this disease involve a combination of prevention, early detection, and advanced treatment […]

Read More →
Smarter Clinical Trial Management in India: Why the FSP Functional Service Provider (FSP) Model Makes Sense

Clinical Trial Management in India can be exciting, but let us be honest, it is not always easy. Sponsors often run into situations where they need extra support for specific parts of a study, but do not want to hand over the whole project. Sometimes they are looking for local experts, other times they just […]

Read More →
AI-Driven Protocol Design for Faster, Smarter Clinical Trials

Applying AI in clinical trials is no longer a futuristic concept; it’s a practical solution gaining traction across the industry. As clinical trials become increasingly complex—with growing data volumes, escalating costs, and stricter regulatory expectations—AI offers timely support. It is being used to optimize trial design, enhance site and patient selection, identify operational risks early, […]

Read More →
Bioavailability (BA) and Bioequivalence (BE) Studies For Nutraceuticals

Bioavailability (BA) and Bioequivalence (BE) studies provide the evidence needed to prove consistency, efficacy, and product quality for the nutraceutical products. With the growing demand for science-backed nutraceuticals, demonstrating how well a product is absorbed and performs in the body is becoming essential. While these studies are well-established in pharmaceuticals, applying them to nutraceuticals presents […]

Read More →